Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study

Leuk Res. 2025 Jul:154:107719. doi: 10.1016/j.leukres.2025.107719. Epub 2025 May 27.
No abstract available

Keywords: Myelofibrosis; Propensity score matching; Ruxolitinib; Second-line therapy.

Publication types

  • Letter